Overview

This monthly update from Reed Smith offers a summary of all the business, regulatory and legal developments in China relevant to drug, device, and life science/health care companies.

General overviews are provided for a variety of news stories and regulation udpates, including:
● Ministry of Health aims to reduce registration time in hospital to under 10 minutes;
● Ministry of Public Health invites the public to comment on the clinical application of antibiotics;
● a new joint US-China initiative to improve product safety;
● Shanghai Pharmaceuticals Holding Co., which has almost $2.5 billion in cash, may make its first acquisition outside China by the end of the year;
● new regulations on reporting health supervision;
● 48 kinds of prescription drugs to be reclassified as OTC drugs;
● a pilot scheme allowing certain physicians to practice medicine in up to three different cities.

For more details on these stories and more, click 'View Briefing'.